Guggenheim Reiterates Buy Rating on Guardant Health, Inc. (GH)

Market Context

Guardant Health, Inc. operates in the Healthcare sector. The stock currently trades at $150.90 with a market capitalization of $12.6B. The stock has gained 199.0% over the past 52 weeks.

Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Guardant Health, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Guardant Health, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jun 29, 2026	Guggenheim	Buy	N/A
Jun 26, 2026	Bernstein	Outperform	N/A
Jun 24, 2026	Barclays	Overweight	N/A
Jun 11, 2026	RBC Capital	Outperform	N/A
Jun 08, 2026	Mizuho	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View GH Stock Page